Related Experiment Video
Updated: Sep 11, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Ventriculitis: A Retrospective Cohort Study of Clinical Features, Outcomes and Device Management Practices
Alejandro Díez-Vidal1,2, Fernando Fernández-Hinojal3, Cristina Marcelo-Calvo1,2,4
1Infectious Diseases Unit, Department of Internal Medicine, La Paz University Hospital, Madrid, Spain.
Background:
Ventriculitis is a severe central nervous system infection, often secondary to intraventricular device use or neurosurgical procedures, with high morbidity and mortality. Diagnostic criteria remain debated, and treatment strategies lack standardization.
Methods:
We conducted a retrospective cohort study from 2014 to 2022 to describe the clinical characteristics, microbiological profile, treatment strategies, and outcomes of ventriculitis at a tertiary care center. Additionally, we compared outcomes before and after the implementation of an updated intraventricular device management protocol.
Results:
A total of 403 positive cerebrospinal fluid cultures were identified during the study period. Among these, 87 fulfilled clinical and microbiological criteria for ventriculitis. Healthcare-associated cases predominated (73 [83.9%]), with neurosurgical interventions (72 [82.8%]) and external ventricular drain use (54 [62.1%]) as the most prevalent risk factors. The most common pathogens were coagulase-negative staphylococci (42 [48.3%]), particularly Staphylococcus epidermidis (33 [37.9%]). Fever (56 [64.4%]) and altered consciousness (40 [45.9%]) were the most frequent symptoms. Attributable mortality reached 33.3% (29/87), increasing to 39.1% (34/87) within 1 year postepisode. The introduction of the updated protocol may have contributed to a reduction in mortality between the study periods (relative risk, 0.45 [95% confidence interval, .32-.78]; P = .003). Among discharged patients, 67.3% (37/55) experienced neurological sequelae. Predictors of higher mortality included CSF protein ≥1 mg/mL at diagnosis and a Glasgow Coma Scale score ≤8 during the clinical course.
Conclusions:
Ventriculitis remains a complex and life-threatening condition with considerable diagnostic and management challenges. Our findings suggest that standardized intraventricular device care protocols may contribute to improved outcomes, although further evaluation is needed.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Pericarditis III: Medical Management
Mitral Regurgitation III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis

